Invention Grant
- Patent Title: Synthetic route to anti-viral agents
-
Application No.: US15804485Application Date: 2017-11-06
-
Publication No.: US10077256B2Publication Date: 2018-09-18
- Inventor: Russell D. Cink , Kirill A. Lukin , Marvin R. Leanna , Matthew J. Pelc , Timothy B. Towne , Dennie S. Welch , Kenneth M. Engstrom , Matthew M. Ravn , Richard D. Bishop , Gang Zhao , Jianzhang Mei , Jeff M. Kallemeyn , David R. Hill , Michael J. Abrahamson , Westin H. Morrill
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: Foley Hoag, LLP
- Agent Dana M. Gordon
- Main IPC: C07D403/12
- IPC: C07D403/12 ; C07C67/08 ; C07C41/26 ; C07C269/04 ; C07C269/06 ; C07D487/04 ; C07C43/196 ; C07C69/74 ; C07C271/34 ; C07D405/06 ; C07D241/44 ; C07D405/14
Abstract:
The invention provides methods of synthesizing a viral protease inhibitor in high yield, without using expensive catalysts or challenging reaction conditions.
Public/Granted literature
- US20180057482A1 SYNTHETIC ROUTE TO ANTI-VIRAL AGENTS Public/Granted day:2018-03-01
Information query
